XORTX Therapeutics Inc.
XORTX Therapeutics Inc. (XRTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XRTX · as of Jun 9, 2026
Key Statistics
Explore XORTX Therapeutics Inc. Data
xrtx stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
xrtx competitorsXRTX
ATXI
DRMA
ELAB
GTBP
LEXXStock Performance
Full HistoryAbout XORTX Therapeutics Inc.
XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insul…
what is xortx therapeutics inc. · xrtx stock overview · xortx therapeutics inc. company profile · who is xortx therapeutics inc. ceo · xrtx NASDAQ · xortx therapeutics inc. headquarters · xortx therapeutics inc. business segments
About Stock Overview & Key Data
XORTX Therapeutics Inc. (XRTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 23, 2021. As of the latest trading session, XRTX stock price is $2.18, with a market capitalization of $607,106. The stock has returned -51.12% over the past 12 months and -22.42% year-to-date.
In fiscal year 2025, XORTX Therapeutics Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, XORTX Therapeutics Inc. (XRTX) stock price is $2.18. The stock is traded on NASDAQ under the ticker symbol XRTX. The 52-week range is $1.73 – $7.05.